Review Article
Neuropharmacological Potential and Delivery Prospects of Thymoquinone for Neurological Disorders
Figure 2
Different formulation of TQ as candidates for neurological disorders. TQ-SLN: TQ solid lipid nanoparticle; TQ-LP: TQ liposome; TQ-SNEDDS: TQ self-nanoemulsifying drug delivery systems; TQ-CPLGA: TQ PLGA-chitosan nanoparticle; TQ-NLC: TQ-loaded nanostructured lipid carrier. It has been proposed that all formulations might have a potential for greater neuropharmacological effects and are probable candidates for treating neurological disorders.